$7.15
-0.10[-1.38%]
At close: Apr 22
$7.15
0[0.00%]
PreMarket: 7:33PM EDT
Fulcrum Therapeutics
(NASDAQ:FULC)Fulcrum Therapeutics Stock (NASDAQ:FULC), Earnings Estimates, EPS, and Revenue
Fulcrum Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 27
EPS
$-0.400
Quarterly Revenue
$871K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$2.8M
Analyze the earnings history of Fulcrum Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/13/2024 | AM | FULC | Q1 | -$0.41 | — | — | — | $259.00K | — | — | — | Get Alert |
| 02/27/2024 | AM | FULC | Q4 | -$0.50 | -$0.43 | -$0.40 | 6.98% | $685.00K | $460.00K | $871.00K | 89.35% | Get Alert |
| 11/07/2023 | AM | FULC | Q3 | -$0.51 | -$0.44 | -$0.39 | 11.36% | $1.18M | $1.05M | $759.00K | -27.71% | Get Alert |
| 08/03/2023 | AM | FULC | Q2 | -$0.83 | -$0.44 | -$0.38 | 13.64% | $1.88M | $1.60M | $880.00K | -45.00% | Get Alert |
| 05/15/2023 | AM | FULC | Q1 | -$0.64 | -$0.46 | -$0.41 | 10.87% | $2.59M | $1.13M | $259.00K | -77.08% | Get Alert |
| 03/09/2023 | AM | FULC | Q4 | -$0.58 | -$0.49 | -$0.50 | -2.04% | $5.06M | $1.65M | $685.00K | -58.48% | Get Alert |
| 11/08/2022 | AM | FULC | Q3 | -$0.57 | -$0.62 | -$0.51 | 17.74% | $4.93M | $2.54M | $1.18M | -53.43% | Get Alert |
| 08/11/2022 | AM | FULC | Q2 | -$0.60 | -$0.66 | -$0.83 | -25.76% | $4.38M | $2.96M | $1.88M | -36.42% | Get Alert |
| 05/09/2022 | AM | FULC | Q1 | -$0.54 | -$0.63 | -$0.64 | -1.59% | $4.79M | $3.94M | $2.59M | -34.21% | Get Alert |
| 03/03/2022 | AM | FULC | Q4 | -$0.64 | -$0.73 | -$0.58 | 20.55% | $4.22M | $2.68M | $5.06M | 88.73% | Get Alert |
| 11/04/2021 | AM | FULC | Q3 | -$0.70 | -$0.65 | -$0.57 | 12.31% | $1.85M | $2.25M | $4.93M | 119.33% | Get Alert |
| 08/10/2021 | AM | FULC | Q2 | -$0.66 | -$0.62 | -$0.60 | 3.23% | $2.00M | — | $4.38M | — | Get Alert |
| 05/06/2021 | AM | FULC | Q1 | -$0.81 | -$0.66 | -$0.54 | 18.18% | $750.00K | $1.42M | $4.79M | 237.25% | Get Alert |
| 03/04/2021 | AM | FULC | Q4 | -$0.71 | — | -$0.64 | — | $0.00 | $1.31M | $4.22M | 222.52% | Get Alert |
| 11/10/2020 | AM | FULC | Q3 | -$0.97 | -$0.65 | -$0.70 | -7.69% | $0.00 | $550.00K | $1.85M | 236.00% | Get Alert |
| 08/11/2020 | AM | FULC | Q2 | -$9.21 | -$0.78 | -$0.66 | 15.38% | $0.00 | — | $2.00M | — | Get Alert |
| 05/13/2020 | AM | FULC | Q1 | — | -$0.75 | -$0.81 | -8.00% | — | — | $750.00K | — | Get Alert |
| 03/05/2020 | AM | FULC | Q4 | -$7.82 | -$0.83 | -$0.71 | 14.46% | — | — | $0.00 | — | Get Alert |
| 11/14/2019 | AM | FULC | Q3 | — | -$2.98 | -$0.97 | 67.45% | — | — | $0.00 | — | Get Alert |
FAQ
When is Fulcrum Therapeutics (NASDAQ:FULC) reporting earnings?
Fulcrum Therapeutics (FULC) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on February 27, 2024 for Q4.
What were the latest earnings per share (EPS) for Fulcrum Therapeutics (NASDAQ:FULC)?
The Actual EPS was $-0.40, which beat the estimate of $-0.43.
What were Fulcrum Therapeutics’s (NASDAQ:FULC) revenues?
The Actual Revenue was $871K, which beat the estimate of $460K.
Browse earnings estimates, EPS, and revenue on all stocks.